Startseite Propylthiouracil hepatitis: report of a case and extensive review of the literature
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Propylthiouracil hepatitis: report of a case and extensive review of the literature

  • Eleni Memi , Spiros Karras , Themistoklis Tzotzas und Gerasimos E. Krassas EMAIL logo
Veröffentlicht/Copyright: 15. März 2012
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Band 25 Heft 3-4

Abstract

Antithyroid drugs (ATDs) have been widely and effectively used for the treatment of pediatric and adult thyrotoxicosis for more than a half century. Since the very beginning of ATD use, reports of hepatic dysfunction related to propylthiouracil (PTU) therapy have been published. We describe a case of a 12-year-old girl, who, after 4 weeks of therapy for Graves disease (GD) with PTU (300 mg/day at 100 mg given three times a day), developed fatigue, fever, diarrhea, nausea, and vomiting. The initial diagnosis was “viral gastrointestinal infection”. Few days after the initiation of her symptoms, the patient developed jaundice, hepatic tenderness, and dark urine. She was admitted to the hospital where, after an extensive investigation, it was found that serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) were elevated (2312 and 1435 IU/L, respectively), alkaline phosphatase (ALP) was 171 IU/L and total bilirubin was 12.7 mg/dL, whereas direct bilirubin was 7.6 mg/dL and prothrombin time was 23.2 s (normal ratio, <14.5 s). Serology for hepatitis A and B was negative. The diagnosis of PTU-induced hepatitis was established. PTU was discontinued, and a treatment with prednisone (50 mg/day) and vitamin K was initiated. Four weeks after admission, her hepatic tests returned to normal. We searched the English literature and we present details of all cases with PTU-related hepatic toxicity in children and adolescents published so far. Also, we provide information regarding the mechanisms and treatment of this appalling clinical entity. Finally, after recent recommendations from American Thyroid Association (ATA) and European Thyroid Association (ETA), PTU should be administered only in the first trimester of pregnancy and in cases of drug allergy to methimazole.


Corresponding author: Prof. Gerasimos E. Krassas, MD, PhD, FRCP (Lond), Tsimiski 92, 54622 Thessaloniki, Greece Phone/Fax: +30 231 0309351

Received: 2011-10-27
Accepted: 2012-2-1
Published Online: 2012-3-15
Published in Print: 2012-04-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Review Articles
  2. Peptide YY in children: a review
  3. Brown adipose tissue: distribution and influencing factors on FDG PET/CT scan
  4. Mini Review
  5. Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism
  6. Original Articles
  7. Current normal values for TSH and FT3 in children are too low: evidence from over 11,000 samples
  8. Elevated serum ferritin and soluble transferrin receptor in infants with congenital hypothyroidism
  9. Implications of gastrointestinal hormones in the pathogenesis of obesity in prepubertal children
  10. Oxidative stress in obese children and its relation with insulin resistance
  11. Final height in elite male artistic gymnasts
  12. Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature
  13. Evaluation of skeletal maturity score for Korean children and the standard for comparison of bone age and chronological age in normal children
  14. Children and adolescent acceptability of a new device system to administer human growth hormone – a pilot study
  15. The analysis of clinical manifestations and genetic mutations in Chinese boys with primary adrenal insufficiency
  16. Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns
  17. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone
  18. Evaluation of serum kisspeptin levels in girls in the diagnosis of central precocious puberty and in the assessment of pubertal suppression
  19. Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth
  20. Patient Reports
  21. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome
  22. Palmoplantar keratoderma with growth hormone deficiency
  23. Propylthiouracil hepatitis: report of a case and extensive review of the literature
  24. Autonomous functioning thyroid nodule successfully treated with radioiodine in a 3 and a half-year-old boy
  25. Hashimoto thyroiditis associated with ataxia telangiectasia
  26. Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy
  27. Stroke in a child with Adams-Oliver syndrome and mixed diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome
  28. A novel mutation of the insulin receptor gene in a preterm infant with Donohue syndrome and heart failure
  29. Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas
  30. Successful prospective management of neonatal citrullinemia
  31. A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene
  32. Warburg Micro syndrome
  33. Inguinal ovary as a rare diagnostic sign of Mayer-Rokitansky-Küster-Hauser syndrome
  34. Letters to the Editor
  35. Endocrine disruptors and fulminant type 1 diabetes: is there a link?
  36. The appropriate use of sensitive tests of hypothalamic-pituitary-adrenal-axis suppression
  37. Meetings
  38. Meetings Calendar
  39. Masthead
  40. Masthead
Heruntergeladen am 31.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2011-0442/html
Button zum nach oben scrollen